{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T13:57:13Z","timestamp":1724421433743},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2164-15-390","type":"journal-article","created":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T09:04:27Z","timestamp":1400663067000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin\u2019s lymphoma (NHL)"],"prefix":"10.1186","volume":"15","author":[{"given":"Carlos","family":"Aya-Bonilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa M","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rod","family":"Lea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher K","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyn R","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,21]]},"reference":[{"key":"6081_CR1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 2008, Lyon: International Agency for Research on Cancer (IARC)"},{"issue":"20","key":"6081_CR2","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1182\/blood-2010-06-289561","volume":"116","author":"JJ Turner","year":"2010","unstructured":"Turner JJ, Morton LM, Linet MS, Clarke CA, Kadin ME, Vajdic CM, Monnereau A, Maynadie M, Chiu BC, Marcos-Gragera R, Costantini AS, Cerhan JR, Weisenburger DD: InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 2010, 116 (20): e90-98. 10.1182\/blood-2010-06-289561.","journal-title":"Blood"},{"issue":"3","key":"6081_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/10428190903552104","volume":"51","author":"H Jayasekara","year":"2010","unstructured":"Jayasekara H, Karahalios A, Juneja S, Thursfield V, Farrugia H, English DR, Giles GG: Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia. Leuk Lymphoma. 2010, 51 (3): 456-468. 10.3109\/10428190903552104.","journal-title":"Leuk Lymphoma"},{"key":"6081_CR4","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1200\/JCO.2012.45.0866","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Luminari S, Dondi A, Tucci A, Vitolo U, Rigacci L, Di Raimondo F, Carella AM, Pulsoni A, Merli F, Arcaini L, Angrilli F, Stelitano C, Gaidano G, Dell'Olio M, Marcheselli L, Franco V, Galimberti S, Sacchi S, Brugiatelli M: R-CVP Versus R-CHOP Versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi. J Clin Oncol. 2013, 31: 1506-1513. 10.1200\/JCO.2012.45.0866.","journal-title":"J Clin Oncol"},{"issue":"5","key":"6081_CR5","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.hoc.2008.07.002","volume":"22","author":"JW Friedberg","year":"2008","unstructured":"Friedberg JW, Fisher RI: Diffuse large B-cell lymphoma. Hematol Oncol Clin North Am. 2008, 22 (5): 941-952. 10.1016\/j.hoc.2008.07.002. ix","journal-title":"Hematol Oncol Clin North Am"},{"issue":"18","key":"6081_CR6","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","volume":"23","author":"P Feugier","year":"2005","unstructured":"Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Ferme C, Christian B, Lepage E, Tilly H, Morschhauser F, Gaulard P, Salles G, Bosly A, Gisselbrecht C, Reyes F, Coiffier B: Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte. J Clin Oncol. 2005, 23 (18): 4117-4126. 10.1200\/JCO.2005.09.131.","journal-title":"J Clin Oncol"},{"issue":"5","key":"6081_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/gcc.20856","volume":"50","author":"MR Green","year":"2011","unstructured":"Green MR, Aya-Bonilla C, Gandhi MK, Lea RA, Wellwood J, Wood P, Marlton P, Griffiths LR: Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin\u2019s lymphoma. Genes Chromosomes Cancer. 2011, 50 (5): 313-326. 10.1002\/gcc.20856.","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"6081_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/gcc.22044","volume":"52","author":"C Aya-Bonilla","year":"2013","unstructured":"Aya-Bonilla C, Green MR, Camilleri E, Benton M, Keane C, Marlton P, Lea R, Gandhi MK, Griffiths LR: High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to non-hodgkin\u2019s lymphoma. Genes Chromosom Cancer. 2013, 52 (5): 467-479. 10.1002\/gcc.22044.","journal-title":"Genes Chromosom Cancer"},{"issue":"52","key":"6081_CR9","doi-asserted-by":"publisher","first-page":"8432","DOI":"10.1038\/sj.onc.1207766","volume":"23","author":"R Iuliano","year":"2004","unstructured":"Iuliano R, Le Pera I, Cristofaro C, Baudi F, Arturi F, Pallante P, Martelli ML, Trapasso F, Chiariotti L, Fusco A: The tyrosine phosphatase PTPRJ\/DEP-1 genotype affects thyroid carcinogenesis. Oncogene. 2004, 23 (52): 8432-8438. 10.1038\/sj.onc.1207766.","journal-title":"Oncogene"},{"issue":"4","key":"6081_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1750-3639.2010.00464.x","volume":"21","author":"A Petermann","year":"2011","unstructured":"Petermann A, Haase D, Wetzel A, Balavenkatraman KK, Tenev T, Guhrs KH, Friedrich S, Nakamura M, Mawrin C, Bohmer FD: Loss of the protein-tyrosine phosphatase DEP-1\/PTPRJ drives meningioma cell motility. Brain Pathol. 2011, 21 (4): 405-418. 10.1111\/j.1750-3639.2010.00464.x.","journal-title":"Brain Pathol"},{"issue":"22","key":"6081_CR11","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1038\/sj.onc.1206246","volume":"22","author":"C Ruivenkamp","year":"2003","unstructured":"Ruivenkamp C, Hermsen M, Postma C, Klous A, Baak J, Meijer G, Demant P: LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene. 2003, 22 (22): 3472-3474. 10.1038\/sj.onc.1206246.","journal-title":"Oncogene"},{"issue":"3","key":"6081_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng903","volume":"31","author":"CA Ruivenkamp","year":"2002","unstructured":"Ruivenkamp CA, van Wezel T, Zanon C, Stassen AP, Vlcek C, Csikos T, Klous AM, Tripodis N, Perrakis A, Boerrigter L, Groot PC, Lindeman J, Mooi WJ, Meijjer GA, Scholten G, Dauwerse H, Paces V, van Zandwijk N, van Ommen GJ, Demant P: Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet. 2002, 31 (3): 295-300. 10.1038\/ng903.","journal-title":"Nat Genet"},{"issue":"13","key":"6081_CR13","doi-asserted-by":"publisher","first-page":"10918","DOI":"10.1074\/jbc.M110.205021","volume":"286","author":"D Arora","year":"2011","unstructured":"Arora D, Stopp S, Bohmer SA, Schons J, Godfrey R, Masson K, Razumovskaya E, Ronnstrand L, Tanzer S, Bauer R, Bohmer FD, Muller JP: Protein-tyrosine phosphatase DEP-1 controls receptor tyrosine kinase FLT3 signaling. J Biol Chem. 2011, 286 (13): 10918-10929. 10.1074\/jbc.M110.205021.","journal-title":"J Biol Chem"},{"issue":"7","key":"6081_CR14","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1128\/MCB.21.7.2393-2403.2001","volume":"21","author":"JE Baker","year":"2001","unstructured":"Baker JE, Majeti R, Tangye SG, Weiss A: Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation. Mol Cell Biol. 2001, 21 (7): 2393-2403. 10.1128\/MCB.21.7.2393-2403.2001.","journal-title":"Mol Cell Biol"},{"issue":"21","key":"6081_CR15","doi-asserted-by":"publisher","first-page":"16219","DOI":"10.1074\/jbc.275.21.16219","volume":"275","author":"M Kovalenko","year":"2000","unstructured":"Kovalenko M, Denner K, Sandstrom J, Persson C, Gross S, Jandt E, Vilella R, Bohmer F, Ostman A: Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1. J Biol Chem. 2000, 275 (21): 16219-16226. 10.1074\/jbc.275.21.16219.","journal-title":"J Biol Chem"},{"issue":"4","key":"6081_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1083\/jcb.200209019","volume":"161","author":"MG Lampugnani","year":"2003","unstructured":"Lampugnani MG, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO, Dejana E: Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1\/CD148. J Cell Biol. 2003, 161 (4): 793-804. 10.1083\/jcb.200209019.","journal-title":"J Cell Biol"},{"issue":"33","key":"6081_CR17","doi-asserted-by":"publisher","first-page":"22048","DOI":"10.1074\/jbc.M109.002758","volume":"284","author":"F Sacco","year":"2009","unstructured":"Sacco F, Tinti M, Palma A, Ferrari E, Nardozza AP, van Huijsduijnen Hooft R, Takahashi T, Castagnoli L, Cesareni G: Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1\/2 kinases. J Biol Chem. 2009, 284 (33): 22048-22058. 10.1074\/jbc.M109.002758.","journal-title":"J Biol Chem"},{"issue":"1","key":"6081_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/BJ20071317","volume":"413","author":"N Tsuboi","year":"2008","unstructured":"Tsuboi N, Utsunomiya T, Roberts RL, Ito H, Takahashi K, Noda M, Takahashi T: The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase. Biochem J. 2008, 413 (1): 193-200. 10.1042\/BJ20071317.","journal-title":"Biochem J"},{"issue":"2","key":"6081_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2007.11.024","volume":"28","author":"JW Zhu","year":"2008","unstructured":"Zhu JW, Brdicka T, Katsumoto TR, Lin J, Weiss A: Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity. 2008, 28 (2): 183-196. 10.1016\/j.immuni.2007.11.024.","journal-title":"Immunity"},{"issue":"6","key":"6081_CR20","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1073\/pnas.1106171109","volume":"109","author":"K Takahashi","year":"2012","unstructured":"Takahashi K, Mernaugh RL, Friedman DB, Weller R, Tsuboi N, Yamashita H, Quaranta V, Takahashi T: Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase. Proc Natl Acad Sci. 2012, 109 (6): 1985-1990. 10.1073\/pnas.1106171109.","journal-title":"Proc Natl Acad Sci"},{"issue":"19","key":"6081_CR21","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1091\/mbc.E11-02-0099","volume":"22","author":"JR Whiteford","year":"2011","unstructured":"Whiteford JR, Xian X, Chaussade C, Vanhaesebroeck B, Nourshargh S, Couchman JR: Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148. Mol Biol Cell. 2011, 22 (19): 3609-3624. 10.1091\/mbc.E11-02-0099.","journal-title":"Mol Biol Cell"},{"issue":"7","key":"6081_CR22","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1021\/cb3007192","volume":"8","author":"F Ortuso","year":"2013","unstructured":"Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F: Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation. ACS Chem Biol. 2013, 8 (7): 1497-1506. 10.1021\/cb3007192.","journal-title":"ACS Chem Biol"},{"issue":"2","key":"6081_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1742-4658.2012.08624.x","volume":"280","author":"F Paduano","year":"2013","unstructured":"Paduano F, Dattilo V, Narciso D, Bilotta A, Gaudio E, Menniti M, Agosti V, Palmieri C, Perrotti N, Fusco A, Trapasso F, Iuliano R: Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328. FEBS J. 2013, 280 (2): 401-412. 10.1111\/j.1742-4658.2012.08624.x.","journal-title":"FEBS J"},{"issue":"10","key":"6081_CR24","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1021\/cb300281t","volume":"7","author":"F Paduano","year":"2012","unstructured":"Paduano F, Ortuso F, Campiglia P, Raso C, Iaccino E, Gaspari M, Gaudio E, Mangone G, Carotenuto A, Bilotta A, Narciso D, Palmieri C, Agosti V, Artese A, Gomez-Monterrey I, Sala M, Cuda G, Iuliano R, Perrotti N, Scala G, Viglietto G, Alcaro S, Croce CM, Novellino E, Fusco A, Trapasso F: Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity. ACS Chem Biol. 2012, 7 (10): 1666-1676. 10.1021\/cb300281t.","journal-title":"ACS Chem Biol"},{"issue":"5","key":"6081_CR25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144 (5): 646-674. 10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"5930","key":"6081_CR26","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009, 324 (5930): 1029-1033. 10.1126\/science.1160809.","journal-title":"Science"},{"key":"6081_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fonc.2012.00060","volume":"2","author":"JM Phang","year":"2012","unstructured":"Phang JM, Liu W, Hancock C, Christian KJ: The proline regulatory axis and cancer. Front Oncol. 2012, 2: 60-","journal-title":"Front Oncol"},{"issue":"1","key":"6081_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1582-4934.2009.00939.x","volume":"15","author":"G Catchpole","year":"2011","unstructured":"Catchpole G, Platzer A, Weikert C, Kempkensteffen C, Johannsen M, Krause H, Jung K, Miller K, Willmitzer L, Selbig J, Weikert S: Metabolic profiling reveals key metabolic features of renal cell carcinoma. J Cell Mol Med. 2011, 15 (1): 109-118. 10.1111\/j.1582-4934.2009.00939.x.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"6081_CR29","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1021\/pr8001645","volume":"7","author":"J Wang","year":"2008","unstructured":"Wang J, Yuan Y, Zhou Y, Guo L, Zhang L, Kuai X, Deng B, Pan Z, Li D, He F: Protein interaction data set highlighted with human Ras-MAPK\/PI3K signaling pathways. J Proteome Res. 2008, 7 (9): 3879-3889. 10.1021\/pr8001645.","journal-title":"J Proteome Res"},{"issue":"6","key":"6081_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","volume":"20","author":"M Challa-Malladi","year":"2011","unstructured":"Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV, Dominguez-Sola D, Pasqualucci L, Dalla-Favera R: Combined genetic inactivation of beta2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell. 2011, 20 (6): 728-740. 10.1016\/j.ccr.2011.11.006.","journal-title":"Cancer Cell"},{"issue":"8","key":"6081_CR31","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1074\/jbc.M208381200","volume":"278","author":"DM Hill","year":"2003","unstructured":"Hill DM, Kasliwal T, Schwarz E, Hebert AM, Chen T, Gubina E, Zhang L, Kozlowski S: A dominant negative mutant beta 2-microglobulin blocks the extracellular folding of a major histocompatibility complex class I heavy chain. J Biol Chem. 2003, 278 (8): 5630-5638. 10.1074\/jbc.M208381200.","journal-title":"J Biol Chem"},{"issue":"11","key":"6081_CR32","doi-asserted-by":"publisher","first-page":"9498","DOI":"10.1074\/jbc.M110547200","volume":"277","author":"JM Cunnick","year":"2002","unstructured":"Cunnick JM, Meng S, Ren Y, Desponts C, Wang HG, Djeu JY, Wu J: Regulation of the mitogen-activated protein kinase signaling pathway by SHP2. J Biol Chem. 2002, 277 (11): 9498-9504. 10.1074\/jbc.M110547200.","journal-title":"J Biol Chem"},{"issue":"4","key":"6081_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1182\/blood.V97.4.911","volume":"97","author":"CK Qu","year":"2001","unstructured":"Qu CK, Nguyen S, Chen J, Feng GS: Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood. 2001, 97 (4): 911-914. 10.1182\/blood.V97.4.911.","journal-title":"Blood"},{"issue":"6","key":"6081_CR34","first-page":"853","volume":"90","author":"L Hugues","year":"2005","unstructured":"Hugues L, Cave H, Philippe N, Pereira S, Fenaux P, Preudhomme C: Mutations of PTPN11 are rare in adult myeloid malignancies. Haematologica. 2005, 90 (6): 853-854.","journal-title":"Haematologica"},{"issue":"8","key":"6081_CR35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ejhg.2011.37","volume":"19","author":"MC Jongmans","year":"2011","unstructured":"Jongmans MC, van der Burgt I, Hoogerbrugge PM, Noordam K, Yntema HG, Nillesen WM, Kuiper RP, Ligtenberg MJ, van Kessel AG, van Krieken JH, Kiemeney LA, Hoogerbrugge N: Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. Eur J Hum Genet. 2011, 19 (8): 870-874. 10.1038\/ejhg.2011.37.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"6081_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/blood-2003-11-3876","volume":"104","author":"M Tartaglia","year":"2004","unstructured":"Tartaglia M, Martinelli S, Cazzaniga G, Cordeddu V, Iavarone I, Spinelli M, Palmi C, Carta C, Pession A, Arico M, Masera G, Basso G, Sorcini M, Gelb BD, Biondi A: Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood. 2004, 104 (2): 307-313. 10.1182\/blood-2003-11-3876.","journal-title":"Blood"},{"issue":"3","key":"6081_CR37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1182\/blood-2010-12-322701","volume":"118","author":"K Urso","year":"2011","unstructured":"Urso K, Alfranca A, Mart\u00ednez-Mart\u00ednez S, Escolano A, Ortega I, Rodr\u00edguez A, Redondo JM: NFATc3 regulates the transcription of genes involved in T-cell activation and angiogenesis. Blood. 2011, 118 (3): 795-803. 10.1182\/blood-2010-12-322701.","journal-title":"Blood"},{"issue":"10","key":"6081_CR38","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1182\/blood-2005-02-0493","volume":"106","author":"SZ Glud","year":"2005","unstructured":"Glud SZ, Sorensen AB, Andrulis M, Wang B, Kondo E, Jessen R, Krenacs L, Stelkovics E, Wabl M, Serfling E, Palmetshofer A, Pedersen FS: A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. Blood. 2005, 106 (10): 3546-3552. 10.1182\/blood-2005-02-0493.","journal-title":"Blood"},{"issue":"9","key":"6081_CR39","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1182\/blood-2005-08-3376","volume":"107","author":"ZZ Yang","year":"2006","unstructured":"Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM: Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood. 2006, 107 (9): 3639-3646. 10.1182\/blood-2005-08-3376.","journal-title":"Blood"},{"issue":"20","key":"6081_CR40","doi-asserted-by":"publisher","first-page":"10145","DOI":"10.1158\/0008-5472.CAN-06-1822","volume":"66","author":"ZZ Yang","year":"2006","unstructured":"Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM: Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin\u2019s lymphoma. Cancer Res. 2006, 66 (20): 10145-10152. 10.1158\/0008-5472.CAN-06-1822.","journal-title":"Cancer Res"},{"issue":"7","key":"6081_CR41","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.4049\/jimmunol.161.7.3249","volume":"161","author":"SG Tangye","year":"1998","unstructured":"Tangye SG, Phillips JH, Lanier LL, de Vries JE, Aversa G: CD148: a receptor-type protein tyrosine phosphatase involved in the regulation of human T cell activation. J Immunol. 1998, 161 (7): 3249-3255.","journal-title":"J Immunol"},{"issue":"3","key":"6081_CR42","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1080\/10428190802706665","volume":"50","author":"S Paydas","year":"2009","unstructured":"Paydas S, Seydaoglu G, Ergin M, Erdogan S, Yavuz S: The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas. Leuk Lymphoma. 2009, 50 (3): 366-373. 10.1080\/10428190802706665.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"6081_CR43","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/annonc\/mdn666","volume":"20","author":"J Ruan","year":"2009","unstructured":"Ruan J, Hajjar K, Rafii S, Leonard JP: Angiogenesis and antiangiogenic therapy in non-Hodgkin\u2019s lymphoma. Ann Oncol. 2009, 20 (3): 413-424.","journal-title":"Ann Oncol"},{"issue":"1","key":"6081_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nm0102-68","volume":"8","author":"MA Shipp","year":"2002","unstructured":"Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002, 8 (1): 68-74. 10.1038\/nm0102-68.","journal-title":"Nat Med"},{"issue":"4","key":"6081_CR45","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1182\/blood-2005-10-4296","volume":"108","author":"T Takahashi","year":"2006","unstructured":"Takahashi T, Takahashi K, Mernaugh RL, Tsuboi N, Liu H, Daniel TO: A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis. Blood. 2006, 108 (4): 1234-1242. 10.1182\/blood-2005-10-4296.","journal-title":"Blood"},{"issue":"21","key":"6081_CR46","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.cub.2009.09.048","volume":"19","author":"G Tarcic","year":"2009","unstructured":"Tarcic G, Boguslavsky SK, Wakim J, Kiuchi T, Liu A, Reinitz F, Nathanson D, Takahashi T, Mischel PS, Ng T, Yarden Y: An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis. Curr Biol. 2009, 19 (21): 1788-1798. 10.1016\/j.cub.2009.09.048.","journal-title":"Curr Biol"},{"issue":"8","key":"6081_CR47","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1182\/blood.V91.8.2800.2800_2800_2809","volume":"91","author":"MA de la Fuente-Garcia","year":"1998","unstructured":"de la Fuente-Garcia MA, Nicolas JM, Freed JH, Palou E, Thomas AP, Vilella R, Vives J, Gaya A: CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood. 1998, 91 (8): 2800-2809.","journal-title":"Blood"},{"issue":"2","key":"6081_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0145-2126(02)00086-3","volume":"27","author":"K Toba","year":"2003","unstructured":"Toba K, Hanawa H, Sakaue M, Yoshida K, Itoh H, Tsuchiyama J, Maruyama S, Narita M, Takahashi M, Watanabe K, Aizawa Y: Fc epsilon RI and CD22 mRNA are expressed in early B-lineage and myeloid leukemia cell lines. Leuk Res. 2003, 27 (2): 173-182. 10.1016\/S0145-2126(02)00086-3.","journal-title":"Leuk Res"},{"issue":"24","key":"6081_CR49","doi-asserted-by":"publisher","first-page":"9236","DOI":"10.1128\/MCB.20.24.9236-9246.2000","volume":"20","author":"F Trapasso","year":"2000","unstructured":"Trapasso F, Iuliano R, Boccia A, Stella A, Visconti R, Bruni P, Baldassarre G, Santoro M, Viglietto G, Fusco A: Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). Mol Cell Biol. 2000, 20 (24): 9236-9246. 10.1128\/MCB.20.24.9236-9246.2000.","journal-title":"Mol Cell Biol"},{"issue":"21","key":"6081_CR50","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, Miller TP, LeBlanc M, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Connors JM, Lansdorp PM, Ouyang Q, Lister TA, Davies AJ, Norton AJ, Muller-Hermelink HK, Ott G, Campo E, et al: Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004, 351 (21): 2159-2169. 10.1056\/NEJMoa041869.","journal-title":"N Engl J Med"},{"issue":"22","key":"6081_CR51","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB, Jares P, Martinez A, Lopez-Guillermo A, et al: Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008, 359 (22): 2313-2323. 10.1056\/NEJMoa0802885.","journal-title":"N Engl J Med"},{"issue":"15","key":"6081_CR52","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1093\/bioinformatics\/btl196","volume":"22","author":"J Gould","year":"2006","unstructured":"Gould J, Getz G, Monti S, Reich M, Mesirov JP: Comparative gene marker selection suite. Bioinformatics. 2006, 22 (15): 1924-1925. 10.1093\/bioinformatics\/btl196.","journal-title":"Bioinformatics"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2164-15-390.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T08:41:13Z","timestamp":1689237673000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/1471-2164-15-390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,21]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["6081"],"URL":"https:\/\/doi.org\/10.1186\/1471-2164-15-390","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,21]]},"assertion":[{"value":"21 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"390"}}